# AD-VANCE: Alzheimer's Disease Advanced Network for Variant Exploration

## Agentic AI System for Accelerating Alzheimer's Disease Research

---

## 1. Executive Overview

### Mission Statement
Build an autonomous, agentic AI system that accelerates Alzheimer's disease and related dementias (ADRD) research through intelligent data integration, knowledge graph construction, and automated hypothesis generation—all using publicly available data, models, and tools.

### Primary Scientific Focus
**Multi-omic pathway discovery and biomarker identification for early Alzheimer's disease detection**

This domain offers the highest acceleration potential because:
1. Early detection significantly improves treatment outcomes
2. Multi-omic integration remains a critical unmet need in AD research
3. Biomarker combinations can reveal disease subtypes
4. Public datasets provide sufficient data for robust modeling

---

## 2. System Architecture

### 2.1 High-Level Architecture

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                           AD-VANCE Agentic System                           │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                             │
│  ┌─────────────────────────────────────────────────────────────────────┐    │
│  │                    RESEARCH ORCHESTRATOR AGENT                      │    │
│  │    (Goal Decomposition, Task Planning, Hypothesis Refinement)      │    │
│  └──────────────────────────────┬──────────────────────────────────────┘    │
│                                 │                                            │
│           ┌─────────────────────┼─────────────────────┐                      │
│           │                     │                     │                      │
│           ▼                     ▼                     ▼                      │
│  ┌─────────────────┐   ┌─────────────────┐   ┌─────────────────┐            │
│  │ DATA INTEGRATION│   │ KNOWLEDGE GRAPH │   │  HYPOTHESIS     │            │
│  │    AGENT        │   │    AGENT        │   │  GENERATION     │            │
│  │                 │   │                 │   │     AGENT       │            │
│  └────────┬────────┘   └────────┬────────┘   └────────┬────────┘            │
│           │                     │                     │                      │
│           └─────────────────────┼─────────────────────┘                      │
│                                 │                                            │
│                                 ▼                                            │
│  ┌─────────────────────────────────────────────────────────────────────┐    │
│  │                  VALIDATION & SIMULATION AGENT                       │    │
│  │    (Cross-validation, Survival Analysis, Causal Inference)         │    │
│  └──────────────────────────────┬──────────────────────────────────────┘    │
│                                 │                                            │
│                                 ▼                                            │
│  ┌─────────────────────────────────────────────────────────────────────┐    │
│  │                 REPRODUCIBILITY & AUDIT AGENT                       │    │
│  │    (Lineage Tracking, Decision Logging, Transparency Reports)       │    │
│  └─────────────────────────────────────────────────────────────────────┘    │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘
                                     │
                                     ▼
┌─────────────────────────────────────────────────────────────────────────────┐
│                           DATA SOURCES LAYER                                │
│  ┌──────────────┐ ┌──────────────┐ ┌──────────────┐ ┌──────────────┐       │
│  │    ADNI      │ │   AMP-AD     │ │   ROSMAP     │ │  UK Biobank  │       │
│  │  (Imaging,   │ │ (Multi-omic, │ │ (Brain       │ │  (Genetic,   │       │
│  │   Clinical)  │ │  Proteomics) │ │  Transcript) │ │   Lifestyle) │       │
│  └──────────────┘ └──────────────┘ └──────────────┘ └──────────────┘       │
│  ┌──────────────┐ ┌──────────────┐ ┌──────────────┐ ┌──────────────┐       │
│  │     GEO      │ │  OpenTargets │ │   PubMed    │ │ Clinical    │       │
│  │ (Expression) │ │   (Drug)     │ │  (Literature)│ │  Trials     │       │
│  └──────────────┘ └──────────────┘ └──────────────┘ └──────────────┘       │
└─────────────────────────────────────────────────────────────────────────────┘
                                     │
                                     ▼
┌─────────────────────────────────────────────────────────────────────────────┐
│                            MODELS LAYER                                     │
│  ┌──────────────────┐ ┌──────────────────┐ ┌──────────────────┐           │
│  │  BioBERT/        │ │    Llama-3       │ │     ESM2         │           │
│  │  PubMedBERT      │ │    (Open)        │ │  (Protein)       │           │
│  └──────────────────┘ └──────────────────┘ └──────────────────┘           │
│  ┌──────────────────┐ ┌──────────────────┐ ┌──────────────────┐           │
│  │   Graph Neural   │ │   Survival       │ │   Embedding      │           │
│  │   Networks       │ │   Models         │ │   Models         │           │
│  └──────────────────┘ └──────────────────┘ └──────────────────┘           │
└─────────────────────────────────────────────────────────────────────────────┘
```

### 2.2 Agent Specifications

#### 2.2.1 Research Orchestrator Agent
**Purpose**: Break down high-level research goals into executable sub-tasks

**Capabilities**:
- Goal decomposition using LLM reasoning
- Experiment planning and scheduling
- Task allocation to specialized agents
- Hypothesis refinement loops
- Strategy revision based on intermediate results

**Technical Implementation**:
- LLM-based planning with ReAct pattern
- Task queue management
- Priority scheduling based on expected impact

#### 2.2.2 Data Integration Agent
**Purpose**: Retrieve, clean, and harmonize heterogeneous AD datasets

**Capabilities**:
- API integration with public data sources (ADNI, AMP-AD, GEO, etc.)
- Data cleaning and normalization
- Patient-level data alignment
- Multi-modal data harmonization (omics, imaging, clinical)
- Unified schema generation

**Technical Implementation**:
- Async data fetching with caching
- Standardized data models (OHDSI, HL7 FHIR)
- Batch processing for large datasets

#### 2.2.3 Knowledge Graph Agent
**Purpose**: Build and maintain dynamic Alzheimer-specific knowledge graph

**Capabilities**:
- Entity extraction from literature and databases
- Relationship inference using embeddings
- Graph construction (genes, proteins, pathways, drugs, phenotypes)
- Graph traversal for hypothesis support
- Dynamic graph updates

**Technical Implementation**:
- Neo4j or NetworkX for graph storage
- Entity resolution using embeddings
- Graph neural networks for link prediction

#### 2.2.4 Hypothesis Generation Agent
**Purpose**: Generate novel, testable hypotheses

**Capabilities**:
- Biomarker combination discovery
- Disease subtype identification
- Causal pathway hypotheses
- Drug repurposing candidates
- Reasoning chain generation

**Technical Implementation**:
- Multi-modal pattern recognition
- Causal inference (do-calculus, instrumental variables)
- Knowledge graph traversal for evidence

#### 2.2.5 Validation & Simulation Agent
**Purpose**: Rigorously validate generated hypotheses

**Capabilities**:
- Cross-validation with multiple metrics
- Survival analysis for progression modeling
- Clustering stability assessment
- Causal inference testing
- Baseline comparison

**Technical Implementation**:
- Scikit-learn for ML validation
- Lifelines for survival analysis
- Statistical testing (permutation tests, bootstrapping)

#### 2.2.6 Reproducibility & Audit Agent
**Purpose**: Ensure transparency and reproducibility

**Capabilities**:
- Data lineage tracking
- Decision logging
- Pipeline versioning
- Transparency report generation
- Audit trail maintenance

**Technical Implementation**:
- MLflow for experiment tracking
- DVC for data versioning
- Structured logging (JSON)

---

## 3. Scientific Methodology

### 3.1 Primary Focus: Multi-omic Biomarker Discovery for Early AD Detection

#### Rationale
- Early detection improves treatment outcomes
- Multi-omic integration is under-explored in AD
- Biomarkers can reveal disease subtypes
- Public data availability supports robust modeling

#### Approach
1. **Data Integration**: Combine transcriptomics, proteomics, genomics, and imaging
2. **Feature Engineering**: Domain-informed feature extraction
3. **Multi-modal Learning**: Joint embedding with attention
4. **Subtype Discovery**: Unsupervised clustering with validation
5. **Causal Inference**: Mendelian randomization for biomarker validation

### 3.2 Novel Element: Dynamic Evolving Knowledge Graph

Our innovation is a **self-updating, multi-modal knowledge graph** that:
- Continuously integrates new research findings
- Uses graph neural networks for link prediction
- Provides evidence trails for hypotheses
- Enables causal reasoning over biological pathways

---

## 4. Technical Specifications

### 4.1 Technology Stack

| Component | Technology | Version |
|-----------|------------|---------|
| Language | Python | 3.11+ |
| Framework | PyTorch | 2.0+ |
| Agents | LangChain | 0.3+ |
| Knowledge Graph | NetworkX + Neo4j | 3.4+ |
| Embeddings | Sentence-Transformers | 2.2+ |
| LLMs | Ollama (Llama-3, Mistral) | Latest |
| Workflow | Prefect | 2.0+ |
| Tracking | MLflow | 2.0+ |
| Deployment | Docker + Kubernetes | Latest |

### 4.2 API Integrations

```python
# Public Data Source Integrations
ADNI_API = "https://adni.loni.usc.edu/data-samples/access-data/"
AMP_AD_API = "https://ampadportal.org/api"
GEO_API = "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/"
OPEN_TARGETS_API = "https://api.opentargets.io/v4"
CLINICAL_TRIALS_API = "https://clinicaltrials.gov/api/query/"
GWAS_CATALOG_API = "https://www.ebi.ac.uk/gwas/rest/api/v1"
```

---

## 5. Validation Strategy

### 5.1 Benchmark Datasets
- ADNI (Alzheimer's Disease Neuroimaging Initiative)
- ROSMAP (Religious Orders Study and Memory and Aging Project)
- AMP-AD (Accelerating Medicines Partnership: Alzheimer's Disease)
- UK Biobank (public-access genetic subset)

### 5.2 Baseline Comparisons
1. **Traditional ML**: Random Forest, XGBoost, SVM
2. **Single-omic models**: Transcriptomics-only, proteomics-only
3. **Literature methods**: Published biomarker panels
4. **Domain baselines**: Clinical criteria (MMSE, CSF biomarkers)

### 5.3 Evaluation Metrics
- **Classification**: ROC-AUC, Precision-Recall, F1
- **Survival**: C-index, Hazard Ratios, Kaplan-Meier
- **Clustering**: Adjusted Rand Index, Silhouette Score
- **Discovery**: Novelty score, Biological pathway enrichment

---

## 6. Deployment Specification

### 6.1 Docker Configuration
```yaml
# docker-compose.yml
services:
  orchestrator:
    build: ./agents/orchestrator
    ports:
      - "8000:8000"
  
  data-agent:
    build: ./agents/data_integration
    ports:
      - "8001:8001"
  
  knowledge-graph:
    build: ./agents/knowledge_graph
    ports:
      - "7474:7474"
  
  hypothesis-agent:
    build: ./agents/hypothesis_generation
    ports:
      - "8002:8002"
  
  validation-agent:
    build: ./agents/validation
    ports:
      - "8003:8003"
```

### 6.2 Resource Requirements
- **Development**: 8 CPU, 32GB RAM, 1 GPU
- **Production**: 16 CPU, 64GB RAM, 2 GPUs
- **Storage**: 500GB SSD for data and models

---

## 7. Project Structure

```
AD-VANCE/
├── agents/
│   ├── orchestrator/
│   │   ├── __init__.py
│   │   ├── agent.py
│   │   ├── planner.py
│   │   └── prompts.py
│   ├── data_integration/
│   │   ├── __init__.py
│   │   ├── agent.py
│   │   ├── connectors/
│   │   │   ├── adni.py
│   │   │   ├── ampad.py
│   │   │   ├── geo.py
│   │   │   └── rosmap.py
│   │   └── processors/
│   │       ├── cleaner.py
│   │       └── harmonizer.py
│   ├── knowledge_graph/
│   │   ├── __init__.py
│   │   ├── agent.py
│   │   ├── builder.py
│   │   └── queries.py
│   ├── hypothesis_generation/
│   │   ├── __init__.py
│   │   ├── agent.py
│   │   ├── biomarker_finder.py
│   │   └── drug_repurposing.py
│   ├── validation/
│   │   ├── __init__.py
│   │   ├── agent.py
│   │   ├── benchmarks.py
│   │   └── statistics.py
│   └── reproducibility/
│       ├── __init__.py
│       ├── agent.py
│       ├── logger.py
│       └── tracker.py
├── data/
│   ├── raw/
│   ├── processed/
│   └── cache/
├── models/
│   ├── checkpoints/
│   └── embeddings/
├── notebooks/
│   ├── demo.ipynb
│   ├── analysis.ipynb
│   └── visualization.ipynb
├── docs/
│   ├── whitepaper.md
│   ├── manuscript.md
│   ├── executive_summary.md
│   └── deployment_guide.md
├── scripts/
│   ├── setup.sh
│   ├── test.sh
│   └── benchmark.py
├── docker/
│   ├── Dockerfile
│   ├── docker-compose.yml
│   └── nginx.conf
├── config/
│   ├── defaults.yaml
│   └── logging.yaml
├── requirements.txt
├── pyproject.toml
├── README.md
├── LICENSE
└── CONTRIBUTING.md
```

---

## 8. Success Metrics

| Metric | Target | Measurement |
|--------|--------|-------------|
| Hypothesis Novelty Score | >0.7 | Literature similarity < 30% |
| Discovery Acceleration | 10x | Time vs manual research |
| Graph Completeness | >80% | Gene/protein coverage |
| Cross-dataset Reproducibility | >0.85 | ROC-AUC correlation |
| Pathway Enrichment | FDR < 0.05 | GO/KEGG enrichment |
| Clinical Relevance | Validated | Expert review |

---

## 9. Risk Analysis

| Risk | Likelihood | Impact | Mitigation |
|------|------------|--------|------------|
| API rate limits | High | Medium | Caching, async requests |
| Data quality issues | Medium | High | Robust cleaning pipeline |
| Model hallucination | Medium | High | Evidence-based verification |
| Computational limits | Medium | Medium | Cloud scaling, optimization |
| Knowledge graph drift | Low | Medium | Version control, validation |

---

## 10. Timeline (12-Week Plan)

| Week | Milestone |
|------|-----------|
| 1-2 | Project setup, agent framework |
| 3-4 | Data integration pipelines |
| 5-6 | Knowledge graph construction |
| 7-8 | Hypothesis generation engine |
| 9-10 | Validation system |
| 11 | Integration, testing |
| 12 | Documentation, demo |

---

## 11. Open Science Alignment

### Data Sharing
- All datasets are public/approved for research
- Output data will be shared via Zenodo
- Code available on GitHub (MIT License)

### Governance
- Open contribution model
- Community advisory board
- Regular public updates

### Ethics
- Bias analysis included
- Privacy-preserving methods
- Clinical misuse prevention
- Transparent limitations

---

## 12. Innovation Summary

**Novel Element**: Dynamic Evolving Multi-modal Knowledge Graph with Causal Reasoning

**Why It's Novel**:
1. Self-updating from literature and databases
2. Joint representation of multi-omic data
3. Causal pathway inference using do-calculus
4. Real-time hypothesis evidence retrieval

**Expected Impact**:
- 10x faster hypothesis generation
- Novel biomarker combinations
- Drug repurposing candidates
- Subtype-specific insights

---

*Document Version: 1.0*
*Generated for: Alzheimer's Disease Data Initiative Prize Competition*
